Skip to main content
Clinical Trials/NCT05343130
NCT05343130
Recruiting
Not Applicable

Efficacy of a Therapy With Brain-Computer Interface Controlled Functional Electrical Stimulation for Neurorehabilitation of Patients With Spinal Cord Injury (Eficacia de Una Terapia Con estimulación eléctrica Funcional Controlada Con Interfaz Cerebro-computadora Para neurorrehabilitación de Pacientes Con lesión Medular)

Instituto Nacional de Rehabilitacion1 site in 1 country32 target enrollmentAugust 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cervical Spinal Cord Injury
Sponsor
Instituto Nacional de Rehabilitacion
Enrollment
32
Locations
1
Primary Endpoint
Capabilities of Upper Extremities Questionnaire (CUE-Q)
Status
Recruiting
Last Updated
10 months ago

Overview

Brief Summary

The study's main goal is to determine the efficacy of a therapy with brain-computer interface controlled functional electrical stimulation for neurorehabilitation of spinal cord injury patients' upper limbs. For this purpose, a randomized controlled trial will be performed to compare the clinical and physiological effects of the brain-computer interface therapy with those of a sham intervention comprised by the application of functional electrical stimulation independently of brain-computer interface control.

Registry
clinicaltrials.gov
Start Date
August 1, 2022
End Date
December 1, 2027
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jessica Cantillo-Negrete

Researcher in Medical Sciences

Instituto Nacional de Rehabilitacion

Eligibility Criteria

Inclusion Criteria

  • Spinal Cord Injury at neurological levels C6 or C7
  • American Spinal Injury Association (ASIA) classification A, B, C or D
  • Upper limb spasticity of less or equal to +1 measured with the Modified Ashworth Scale
  • Time since disease onset of more than 6 months and less than 60 months
  • Normal or corrected to normal vision

Exclusion Criteria

  • Severe attention deficits
  • Previous diagnosis of traumatic brain injury
  • Previous diagnosis of peripheral nerve injury
  • Previous stroke diagnosis
  • Previous diagnosis of neurodegenerative diseases
  • History of fractures in upper extremities
  • Skin lesions
  • Contractures in upper extremities that hamper mobility
  • Excessive muscle spasms

Outcomes

Primary Outcomes

Capabilities of Upper Extremities Questionnaire (CUE-Q)

Time Frame: At enrollment and after 7 weeks of the intervention onset

Change of the functional limitation in tetraplegia. Scale ranges from 32 to 224 points if both upper limbs are assessed. A higher score means less functional limitation outcome.

Action Research Arm Test (ARAT)

Time Frame: At enrollment and after 7 weeks of the intervention onset

Change of upper limbs function. Scale ranges from 0 to 57 points for each upper limb. A higher score means a better upper limb function.

Upper Extremity Motor Score (UEMS)

Time Frame: At enrollment and after 7 weeks of the intervention onset

Change of upper limbs function. Scale ranges from 0 to 50 points if both upper limbs are assessed. A higher score means a better upper limb function.

Secondary Outcomes

  • Spinal Cord Independence Measure III (SCIM-III)(At enrollment and after 7 weeks of the intervention onset)
  • Life Satisfaction Questionnaire 9 (LISAT-9)(At enrollment and after 7 weeks of the intervention onset)

Study Sites (1)

Loading locations...

Similar Trials